Trending News
News
News
Verona Pharma Appoints New CEO
Appointment of experienced biotechnology CEO as part of succession planning.
News
New Biomarkers Could Offer Vital Clues for Cancer Research
European funding for cancer research has led to some interesting results in recent years, says Carl-Johan Ivarsson, CEO at Qlucore.
News
Oncolytics Enters into Sponsorship Agreement with NCIC CTG
Agreement at Queen's University for randomized phase II study in colorectal cancer.
News
Idera Pharmaceuticals Announces Top-line Results from Phase 2 Clinical Trial
IMO-2055 to be used in treatment of patients with advanced head and neck cancer.
News
Urinary Excretion of Platinum, Arsenic and Selenium of Cancer Patients Treated with Platinum-Based Drugs
Arsenic exposure increases the risk of non-cancerous and cancerous diseases. This study characterised the short-term urinary excretion amounts of arsenic, selenium and platinum in 24-h urine samples from patients with lung cancer and those with other types of cancer.
News
Urinary Excretion of Platinum, Arsenic and Selenium of Cancer Patients Treated with Platinum-Based Drugs
Arsenic exposure increases the risk of non-cancerous and cancerous diseases. This study characterised the short-term urinary excretion amounts of arsenic, selenium and platinum in 24-h urine samples from patients with lung cancer and those with other types of cancer.
News
Creabilis Appoints Dr Simon Russell as Chief Business Officer
Dr Russell to maximize the commercial potential of Company’s products and technology.
News
Mucosis Announces Publication of Preclinical Data of Novel Influenza Vaccines
Mucosally administered Mimopath-based influenza vaccine protects against both homologous and heterologous challenge.
News
Nuvo Research Announces 2012 First Quarter Results
U.S. prescriptions of Pennsaid continued to grow quarter-over-quarter.
News
Prosonix Demonstrates Improved Delivery and Co-localization of Respiratory Medicines
New review published in European Respiratory Disease(ERD).
Advertisement
